These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19221448)

  • 1. Bilateral uveitis secondary to bisphosphonate therapy.
    Tan YL; Sims J; Chee SP
    Ophthalmologica; 2009; 223(3):215-6. PubMed ID: 19221448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD; Margo CE
    Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-associated orbital inflammatory disease and uveitis anterior--a case report and review.
    Böni C; Kordic H; Chaloupka K
    Klin Monbl Augenheilkd; 2013 Apr; 230(4):367-9. PubMed ID: 23629782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BISPHOSPHONATES AND OCULAR INFLAMMATION].
    Rappoport D; Leiba H
    Harefuah; 2017 Feb; 156(2):71-73. PubMed ID: 28551891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
    Assael LA
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced optic neuritis and uveitis secondary to bisphosphonates.
    Stack R; Tarr K
    N Z Med J; 2006 Mar; 119(1230):U1888. PubMed ID: 16532052
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
    Oizumi T; Yamaguchi K; Funayama H; Kuroishi T; Kawamura H; Sugawara S; Endo Y
    Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveitis, an under-recognized adverse effect of pamidronate. Case report and literature review.
    Rey J; Daumen-Legré V; Pham T; Bernard P; Dahan L; Acquaviva PC; Lafforgue P
    Joint Bone Spine; 2000; 67(4):337-40. PubMed ID: 10963085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
    Etminan M; Forooghian F; Maberley D
    CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rifabutin-associated with bilateral uveitis in an HIV negative patient].
    Müller K; Grieshaber MC; Orgül S
    Klin Monbl Augenheilkd; 2008 May; 225(5):448-50. PubMed ID: 18454395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short course of cyclophosphamide therapy may reduce recurrence in patients with tubulointerstitial nephritis and uveitis syndrome.
    Taheri S; Taheri D
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):655-7. PubMed ID: 19587511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bisphosphonates-associated osteonecrosis in rheumatoid arthritis.
    Junquera L; Gallego L; Pelaz A; Olay S
    Med Oral Patol Oral Cir Bucal; 2009 Jun; 14(6):E292-4. PubMed ID: 19300372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two differing presentations of chronic bilateral anterior uveitis.
    Hanno E; Gay D; Boyer S
    Optometry; 2009 Feb; 80(2):70-5. PubMed ID: 19187894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminobisphosphonate-associated orbital and ocular inflammatory disease.
    Keren S; Leibovitch I; Ben Cnaan R; Neudorfer M; Fogel O; Greenman Y; Shulman S; Zur D; Habot-Wilner Z
    Acta Ophthalmol; 2019 Aug; 97(5):e792-e799. PubMed ID: 30816018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates: bone, muscle and joint pain.
    Prescrire Int; 2009 Feb; 18(99):23. PubMed ID: 19391290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iritis presumed as secondary to disseminated coccidioidomycosis.
    Hwang JM; Pian D
    Optometry; 2006 Nov; 77(11):547-53. PubMed ID: 17145566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular features in neurosarcoidosis.
    Menezo V; Lobo A; Yeo TK; du Bois RM; Lightman S
    Ocul Immunol Inflamm; 2009; 17(3):170-8. PubMed ID: 19585359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
    Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
    J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.